Neurovascular

In October 2026, the Canary Islands Healthcare Evaluation Service (SESCS), operating within the Spanish Network of Health Technology Assessment Agencies (RedETS), published several New and Emerging Health Technology Fact Sheets. The publications cover technologies across gastrointestinal, gynecological, pulmonary, neurovascular, diagnostic imaging, and in vitro diagnostic fields. The purpose of the Fact Sheets is to inform the prioritization of new and emerging technologies for evaluation by RedETS.

On October 5, 2026, the updated version of the intra-DRG list was published in France. Two new devices were registered in the neurovascular field (thromboaspiration catheters CEREGLIDE 92 and Broadway 8). Other changes included a few delistings and renewal and/or modification of registration conditions for several devices.

On September 24, 2026, the Spanish Ministry of Health launched a hearing and public information procedure on a Draft Order updating the rules governing the Health Cohesion Fund (FCS). The update aims to align the Fund’s compensation system with current NHS healthcare needs, with changes expected across endocrine, gastrointestinal, endoscopy, extracorporeal treatments, neurology and neurosurgery, neurovascular, in-vitro diagnostics, and some other areas. Comments may be submitted until October 16, 2026.

In August 2026, the Finnish Coordinating Center for Health Technology Assessment announced the completion of five rapid hospital HTAs in diagnostic imaging, gastrointestinal, neurovascular, peripheral vascular, and some other fields.

On July 1, 2026, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the Nomenclature of healthcare services. Several new procedure codes were introduced concerning neurovascular, gynecology, and eHealth fields.

In April 2026, the National Institute for Health and Care Excellence (NICE) published two new HealthTech Guidances (HTGs) on transvenous embolization for spontaneous intracranial hypotension caused by a cerebrospinal fluid (CSF) venous fistula and digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centers. In addition, four clinical guidelines were updated.

On January 30, 2026, the Institute for the Hospital Remuneration System (InEK) published the list of innovation funding (NUB) requests submitted by hospitals in 2025. The medical technologies of cardiovascular, endoscopy, extracorporeal, gastrointestinal, neuromodulation, peripheral vascular, and other technology groups obtained a positive status 1.

On November 28, 2025, the entity managing the DRG system in Switzerland, SwissDRG, published the final (billing) version of the 2026 DRG system. In total, 19 new DRGs related to cardiovascular, ENT, gastrointestinal, neurology and neurosurgery, obstetrics and gynecology, orthopedics, and some other fields were introduced. Also, four new add-on reimbursement categories were added.

In August 2025, the updated version of the intra-DRG list was published in France. One new device was registered in the neurovascular field (BOBBY balloon guide catheter). Another change concerned the renewal of the registration for one device.

In June 2025, Belgian INAMI/RIZIV updated the List of implants and invasive medical devices. Four new reimbursement codes were added to the List in relation to heart valve replacement. Several Nominative lists of brands were updated as well in the fields of neuromodulation, neurovascular, orthopedic, and cardiovascular.

The French National Authority for Health (HAS) has released new recommendations about add-on reimbursement of medical devices and medical aids from the February 2025 meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Sixteen favorable opinions were published concerning the registration or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). They relate to cardiovascular and peripheral vascular, neurovascular, endocrinology, interventional radiology, nephrology and urology, orthopedic devices, and medical aids.

On January 30, 2025, the Institute for the Hospital Remuneration System (InEK) published the list of requests for innovation funding (NUB) submitted by hospitals in 2024. The medical technologies of cardiovascular, endoscopy, extracorporeal, gastrointestinal, neuromodulation, peripheral vascular, and other technology groups obtained positive status 1.